A natural history analysis of asymptomatic <i>TTR</i> gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS)-Reference-Cited by-同舟云学术

A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS)

Published:2022-06-22 Issue:4 Volume:29 Page:228-236
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Coelho Teresa¹,Conceição Isabel²^ORCID,Waddington-Cruz Márcia³,Keohane Denis⁴,Sultan Marla B.⁴,Chapman Doug⁴,Amass Leslie⁴,

Affiliation:

1. Unidade Corino Andrade, Hospital Santo António, Centro Hospitalar Universitário do Porto, Porto, Portugal

2. Hospital de Santa Maria – CHULN and FML, Universidade de Lisboa, Lisbon, Portugal

3. University Hospital, CEPARM, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

4. Pfizer Inc., New York, NY, USA

Funder

Pfizer

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2022.2070470

Reference30 articles.

1. Guideline of transthyretin-related hereditary amyloidosis for clinicians

2. Rowczenio D, Wechalekar A. Mutations in hereditary amyloidosis [Internet]. 2015. [cited 2021 Oct 11]. Available from: http://amyloidosismutations.com/mut-attr.php.

3. Evolving landscape in the management of transthyretin amyloidosis

4. Transthyretin Amyloid Cardiomyopathy

5. “Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and biochemical characterization of asymptomatic carriers and symptomatic patients with hereditary transthyretin amyloidosis caused by TTR V30L mutation;Neurological Sciences;2024-09-14

2. Phenotypic presentation of family members of ATTRv probands and subsequent disease penetrance;2024-09-07

3. Amyloid Neuropathy: From Pathophysiology to Treatment in Light‐Chain Amyloidosis and Hereditary Transthyretin Amyloidosis;Annals of Neurology;2024-06-24

4. Autonomic Dysfunction from Diagnosis to Treatment;Primary Care: Clinics in Office Practice;2024-06

5. Early diagnosis in ATTRv amyloidosis, how early is enough? How early is possible?;Medicina Clínica;2024-06